Caerus Investment Advisors »

Regeneron Pharmaceuticals shares owned by Caerus Investment Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Caerus Investment Advisors from 13F filings

Historical chart of Caerus Investment Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Caerus Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Caerus Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $747k 1.3k 562.27

More positions owned by Caerus Investment Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Global X Fds S&p 500 Covered (XYLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Global X Fds Nasdaq 100 Cover (QYLD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Alphabet Cap Stk Cl A (GOOGL)
Dimensional Etf Trust Us Equity Market (DFUS)
Microsoft Corporation (MSFT)
Palantir Technologies Cl A (PLTR)

View all positions for Caerus Investment Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals